Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 203Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Apitoria Pharma Private Limited, Unit-II

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

CRS
Not Confirmed
arrow
arrow
CRS
Not Confirmed

The leader

Registrant Name : GlaxoSmithKline Inc.

Registration Date : 2022-10-31

Registration Number : 20221031-209-J-1407

Manufacturer Name : Apitoria Pharma Private Limi...

Manufacturer Address : Survey No. 10 & 13, Gaddapotharam Village, IDA, Kazipally, Jinnaram Mandal,Sangareddy...

blank

Looking for 30516-87-1 / Zidovudine API manufacturers, exporters & distributors?

Zidovudine manufacturers, exporters & distributors 1

88

PharmaCompass offers a list of Zidovudine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Zidovudine manufacturer or Zidovudine supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Zidovudine manufacturer or Zidovudine supplier.

PharmaCompass also assists you with knowing the Zidovudine API Price utilized in the formulation of products. Zidovudine API Price is not always fixed or binding as the Zidovudine Price is obtained through a variety of data sources. The Zidovudine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Zidovudine

Synonyms

Azidothymidine, 30516-87-1, 3'-azido-3'-deoxythymidine, Retrovir, Azt, Zidovudinum

Cas Number

30516-87-1

Unique Ingredient Identifier (UNII)

4B9XT59T7S

About Zidovudine

A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia.

Lamivudine/Zidovudine 150 mg/300 mg Tablets Co-packaged with Nevirapine 200 mg Tablets-1 Manufacturers

A Lamivudine/Zidovudine 150 mg/300 mg Tablets Co-packaged with Nevirapine 200 mg Tablets-1 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lamivudine/Zidovudine 150 mg/300 mg Tablets Co-packaged with Nevirapine 200 mg Tablets-1, including repackagers and relabelers. The FDA regulates Lamivudine/Zidovudine 150 mg/300 mg Tablets Co-packaged with Nevirapine 200 mg Tablets-1 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lamivudine/Zidovudine 150 mg/300 mg Tablets Co-packaged with Nevirapine 200 mg Tablets-1 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Lamivudine/Zidovudine 150 mg/300 mg Tablets Co-packaged with Nevirapine 200 mg Tablets-1 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Lamivudine/Zidovudine 150 mg/300 mg Tablets Co-packaged with Nevirapine 200 mg Tablets-1 Suppliers

A Lamivudine/Zidovudine 150 mg/300 mg Tablets Co-packaged with Nevirapine 200 mg Tablets-1 supplier is an individual or a company that provides Lamivudine/Zidovudine 150 mg/300 mg Tablets Co-packaged with Nevirapine 200 mg Tablets-1 active pharmaceutical ingredient (API) or Lamivudine/Zidovudine 150 mg/300 mg Tablets Co-packaged with Nevirapine 200 mg Tablets-1 finished formulations upon request. The Lamivudine/Zidovudine 150 mg/300 mg Tablets Co-packaged with Nevirapine 200 mg Tablets-1 suppliers may include Lamivudine/Zidovudine 150 mg/300 mg Tablets Co-packaged with Nevirapine 200 mg Tablets-1 API manufacturers, exporters, distributors and traders.

click here to find a list of Lamivudine/Zidovudine 150 mg/300 mg Tablets Co-packaged with Nevirapine 200 mg Tablets-1 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Lamivudine/Zidovudine 150 mg/300 mg Tablets Co-packaged with Nevirapine 200 mg Tablets-1 KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Lamivudine/Zidovudine 150 mg/300 mg Tablets Co-packaged with Nevirapine 200 mg Tablets-1 Drug Master File in Korea (Lamivudine/Zidovudine 150 mg/300 mg Tablets Co-packaged with Nevirapine 200 mg Tablets-1 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Lamivudine/Zidovudine 150 mg/300 mg Tablets Co-packaged with Nevirapine 200 mg Tablets-1. The MFDS reviews the Lamivudine/Zidovudine 150 mg/300 mg Tablets Co-packaged with Nevirapine 200 mg Tablets-1 KDMF as part of the drug registration process and uses the information provided in the Lamivudine/Zidovudine 150 mg/300 mg Tablets Co-packaged with Nevirapine 200 mg Tablets-1 KDMF to evaluate the safety and efficacy of the drug.

After submitting a Lamivudine/Zidovudine 150 mg/300 mg Tablets Co-packaged with Nevirapine 200 mg Tablets-1 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Lamivudine/Zidovudine 150 mg/300 mg Tablets Co-packaged with Nevirapine 200 mg Tablets-1 API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Lamivudine/Zidovudine 150 mg/300 mg Tablets Co-packaged with Nevirapine 200 mg Tablets-1 suppliers with KDMF on PharmaCompass.

Lamivudine/Zidovudine 150 mg/300 mg Tablets Co-packaged with Nevirapine 200 mg Tablets-1 Manufacturers | Traders | Suppliers

Lamivudine/Zidovudine 150 mg/300 mg Tablets Co-packaged with Nevirapine 200 mg Tablets-1 Manufacturers, Traders, Suppliers 1
94

We have 1 companies offering Lamivudine/Zidovudine 150 mg/300 mg Tablets Co-packaged with Nevirapine 200 mg Tablets-1

Get in contact with the supplier of your choice:

  1. Aurobindo Pharma Limited
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.